BioMarin to Present at 34th Annual J.P. Morgan Healthcare Conference in San Francisco
06 January 2016 - 12:30AM
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will
participate in the 34th Annual J.P. Morgan Healthcare Conference on
Monday, January 11, 2016 at 8:30 am PT, or 11:30 am ET, in San
Francisco, California. To access the live webcast, please visit the
investor section of the BioMarin website, www.BMRN.com. A replay
will also be archived on the site for at least one week following
the event.
About BioMarin
BioMarin is a global biotechnology company that
develops and commercializes innovative therapies for patients with
serious and life-threatening rare and ultra-rare genetic diseases.
The company's portfolio consists of five commercialized products
and multiple clinical and pre-clinical product candidates. For
additional information, please visit www.BMRN.com.
Contacts:
Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558
Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Sep 2024 to Oct 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Oct 2023 to Oct 2024